The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, single-arm, multi-institutional phase II trial of avelumab for recurrent, metastatic nasopharyngeal carcinoma.
 
Assuntina Gesualda Sacco
Research Funding - Merck; Pfizer; VentiRx
 
Karen Messer
No Relationships to Disclose
 
Rom S. Leidner
No Relationships to Disclose
 
A. Dimitrios Colevas
Stock and Other Ownership Interests - Gilead Sciences; Pharmacyclics
Research Funding - Bristol-Myers Squibb; Curis; Genentech
 
Jorge J. Nieva
No Relationships to Disclose
 
Nicole Grace Chau
No Relationships to Disclose
 
Chaitali Singh Nangia
No Relationships to Disclose
 
Benjamin Pinsky
No Relationships to Disclose
 
Kathryn A. Gold
Honoraria - Roche/Genentech
Consulting or Advisory Role - ARIAD
Research Funding - ARIAD; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Pharmacyclics; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca
 
Gregory A. Daniels
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Prometheus (Inst); Viralytics (Inst)
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Human Longevity, Inc; Merck; Pfizer
Speakers' Bureau - Bayer; Eisai